Company: PFSA
Filing Date: 2025-09-17
Form Type: S-1/A
Source: 0001213900-25-088333
Chunk: 122

Company: Profusa, Inc.
Filing Date: 2025-09-17
Form: S-1/A
Chunk 122
---
 deficiency; (iii) a third closing for Notes in an aggregate principal amount of $5,555,556 (the “ Third Tranche”) for a purchase price of $5,000,000, subject to the satisfaction of certain conditions including the full conversion or repayment of the First Tranche, effectiveness of a registration statement, no Nasdaq listing deficiency, and receipt of stockholder approval; and (iv) a fourth closing for Notes in an aggregate principal amount of $4,444,444 (the “ Fourth Tranche”) for a purchase price of $4,000,000, subject to the satisfaction of certain conditions including the full repayment of the First and Second Tranches, at least fifty percent (50%) repayment or conversion of the Third Tranche, effectiveness of a registration statement, and no Nasdaq listing deficiency. The Amendment supersedes and replaces all prior provisions relating to “Additional Closings” and “Additional Notes,” and all references to such terms in the PIPE Subscription Agreement and related documents are to be construed in accordance with the new tranche structure. •Concurrently, on August25, 2025, the Company entered into Amendment No. 1 (the “ Note Amendment”) to the Initial Note. The Note Amendment modifies the terms of the Initial Note, specifically amending Section 4(b) to revise the conversion price provisions on any conversion date to be the lower of (i) the Conversion Price on such date and (ii) ninety -fivepercent (95%) of the lowest daily volume weighted average price (“ VWAP”) for the Company’s common stock during the ten consecutive trading days immediately preceding the applicable conversion date (the “ Alternate Conversion Price”), provided that in no event shall the conversion price be less than the Floor Price of twenty percent (20%) of the closing sale price of the common stock on the principal trading market on the trading day immediately preceding the Note Amendment’s effective date, which was August22, 2025. •NorthView’s Convertible Working Capital loan will be being converted subsequent to the close of the Business Combination in a future registration statement. The principal outstanding of the note was $1,919,796 as of June30, 2025 which has been fair value adjusted on the balance sheet at June30, 2025 to $10,288,111 which is included in the pro forma at the current balance as no interest accrues on this note and will be converted into 863,908 shares of New Profusa, at an as converted price of $2.